Delivery Order SPE2DB22D2005-SPE2DB25FJSG7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,065.75 to AmerisourceBergen Drug Corp for 180-count supplies of Janumet XR 50-1,000 mg tablets. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, ultimately completed on August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,909.49 to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.12 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-500 mg tablets (180-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger federal contracting relationship with DLA. The place of performance is located at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,455.38 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg, with an ultimate completion date of July 30, 2025. The contract utilized firm fixed pricing with no set-aside designation, indicating open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.28 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This competitively awarded, non-set-aside contract involves firm fixed pricing and is scheduled for completion by September 2, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,193.47 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) under a firm fixed-price arrangement. The $9,811.62 delivery order, which represents a non-set-aside competitive award, is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its established...
- The Defense Logistics Agency awarded a $5,438.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This is a non-set-aside contract with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger indefinite delivery vehicle, enabling the...
- The Defense Logistics Agency awarded a $6,333.40 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units), with completion expected by August 28, 2025. This non-set-aside competitive award represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSG7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,537.29 to AmerisourceBergen Drug Corp for Janumet XR 50-1,000 mg tablets (60-count) on August 21, 2025, with completion targeted for August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/21/25 |